Northern Trust Corp Isoray, Inc. Transaction History

Northern Trust Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	N/A	451,992 Added 114.92%	845,304 $583,000
Q3 2023 Nov 13, 2023	SELL	N/A	-1,682 Reduced 0.43%	393,312 $271,000
Q1 2023 May 15, 2023	BUY	$0.0 - $0.67 $0 - $100,924	150,634 Added 61.64%	394,994 $252,000
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.37 $4,469 - $6,359	-17,189 Reduced 6.57%	244,360 $76,000
Q3 2021 Nov 15, 2021	SELL	$0.58 - $0.79 $4,836 - $6,587	-8,338 Reduced 3.09%	261,549 $165,000
Q2 2021 Aug 13, 2021	SELL	$0.75 - $1.15 $10,112 - $15,505	-13,483 Reduced 4.76%	269,887 $215,000
Q1 2021 May 12, 2021	BUY	$0.53 - $2.47 $77,740 - $362,299	146,680 Added 107.31%	283,370 $309,000
Q4 2020 Feb 11, 2021	BUY	$0.36 - $0.58 $9,215 - $14,846	25,598 Added 23.04%	136,690 $62,000
Q3 2020 Nov 16, 2020	SELL	$0.54 - $0.78 $9,036 - $13,052	-16,734 Reduced 13.09%	111,092 $65,000
Q2 2020 Aug 14, 2020	BUY	$0.47 - $0.86 $5,062 - $9,263	10,771 Added 9.2%	127,826 $71,000
Q4 2019 Feb 14, 2020	SELL	$0.3 - $0.69 $786 - $1,809	-2,622 Reduced 2.19%	117,055 $73,000
Q3 2019 Nov 13, 2019	SELL	$0.31 - $0.42 $1,519 - $2,058	-4,900 Reduced 3.93%	119,677 $38,000
Q3 2017 Nov 13, 2017	BUY	$0.51 - $0.6 $63,534 - $74,746	124,577	124,577 $64,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.